G R Wilkinson

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.

Lyle A. Siddoway, Katherine A. Thompson, C B McAllister et al. · Circulation · 1987 · 274 citations

Medicine, Pharmacokinetics, Pharmacology +14

P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies.

Christoph Wandel, Richard B. Kim, Shama Kajiji et al. · PubMed · 1999 · 254 citations

Medicine, Pharmacokinetics, Pharmacology +16

The Raman spectra of ice (I_h, II, III, V, VI and IX) as functions of pressure and temperature

W.F. Sherman, G R Wilkinson · Journal of Physics C Solid State Physics · 1984 · 151 citations

Natural Sciences, Chemistry, Physics +15

Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients.

Kenneth R. Hande, P J Wedlund, Richard M. Noone et al. · PubMed · 1984 · 150 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors.

Amir Kaisary, Patrick J. Smith, E Jaczq et al. · PubMed · 1987 · 147 citations

Medicine, Oncology, Pharmacology +14